Monday, May 24, 2010 8:26:32 PM
I've considered this and I am not bothered by how big the OS is. I am bothered by why the CEO has to keep giving shares away (not including the preferreds that are being converted) so cheaply.
The Company issued 35,050,005 shares of common stock to investors for $1,087,000 (~$0.03 per share)
The Company issued 29,150,000 shares common stock for services and recorded consulting fee expense of $3,963,500 for the issuance of these shares (~$0.136 per share)
OK, so the 2nd one is not so bad. Both of these happened between April and May 20 so what was the difference?
My opinion of the CEO is that he does not have the interest of common shareholders in his heart. I sure would like to know who these investors are that got dirt cheap shares and what their relationship is to the company and/or CEO.
That being said, unless there is outright fraud in the reported increase in revs and orders, I am still here.
The Company issued 35,050,005 shares of common stock to investors for $1,087,000 (~$0.03 per share)
The Company issued 29,150,000 shares common stock for services and recorded consulting fee expense of $3,963,500 for the issuance of these shares (~$0.136 per share)
OK, so the 2nd one is not so bad. Both of these happened between April and May 20 so what was the difference?
My opinion of the CEO is that he does not have the interest of common shareholders in his heart. I sure would like to know who these investors are that got dirt cheap shares and what their relationship is to the company and/or CEO.
That being said, unless there is outright fraud in the reported increase in revs and orders, I am still here.
Recent POSC News
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/31/2026 06:04:15 PM
- Positron Corporation Secures Multiple PET-CT Orders from Leading Nuclear Cardiologist Practices • GlobeNewswire Inc. • 02/17/2026 02:25:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/30/2025 09:30:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/17/2025 03:21:59 PM
- Positron Corporation Announces Its Transition to a Reporting SEC Company • GlobeNewswire Inc. • 11/17/2025 02:19:08 PM
- Form 10-12G - Registration of securities [Section 12(g)] • Edgar (US Regulatory) • 11/12/2025 10:04:03 PM
- Positron Corporation Enters Industry Partnership Agreement with MedAxiom • GlobeNewswire Inc. • 10/02/2025 01:15:00 PM
- Positron Corporation Wins Innovation Award in PET-CT Category from Medical Device Network’s Excellence Awards 2025 • GlobeNewswire Inc. • 10/01/2025 01:15:00 PM
